Versor Investments LP Sells 6,515 Shares of Cardinal Health, Inc. $CAH

Versor Investments LP trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 48.9% during the 4th quarter, Holdings Channel reports. The fund owned 6,798 shares of the company’s stock after selling 6,515 shares during the period. Versor Investments LP’s holdings in Cardinal Health were worth $1,397,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. Integrated Wealth Concepts LLC grew its holdings in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new position in Cardinal Health during the 2nd quarter worth about $1,935,000. Cerity Partners LLC grew its holdings in Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after acquiring an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC grew its holdings in Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.6%

CAH stock opened at $182.63 on Tuesday. The firm has a 50 day moving average of $209.97 and a 200 day moving average of $207.30. The stock has a market capitalization of $42.77 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 1.09 and a beta of 0.53. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the firm posted $2.35 EPS. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.1%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.19%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CAH shares. Jefferies Financial Group raised their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, January 22nd. Barclays boosted their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. Evercore reduced their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Morgan Stanley boosted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Finally, Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.